TheraRadar
Data updated: May 26, 2026

CETIRIZINE HYDROCHLORIDE

Respiratory Approved 2008-05-27

Cetirizine hydrochloride oral solution treats symptoms of year-round allergies in children between 6 and 23 months old. It helps patients with sneezing, runny nose, and itchy eyes caused by common triggers like dust mites, mold, and animal dander. This medication is also used for children up to 5 years of age to manage chronic hives by reducing the frequency and severity of skin outbreaks and itching.

Source: FDA Label • Teva

How CETIRIZINE HYDROCHLORIDE Works

This medication works by selectively inhibiting peripheral H1 receptors to block the effects of histamine. As a metabolite of hydroxyzine, it targets these receptors outside of the central nervous system and shows negligible penetration into the brain. This targeted action helps manage allergic symptoms and skin reactions with minimal impact on other receptor types.

Source: FDA Label
16
Indications
--
Phase 3 Trials
17
Years on Market

CETIRIZINE HYDROCHLORIDE Approval History

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
52 FDA actions from 2008 to 2026
Feb 2026 ORIGINAL
Update
Aug 2025 SUPPL
Mfg · Manufacturing (CMC)
Jul 2025 SUPPL
Label · Labeling

What CETIRIZINE HYDROCHLORIDE Treats

2 indications

CETIRIZINE HYDROCHLORIDE is approved for 2 conditions since its original approval in 2008. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Perennial allergic rhinitis
  • Chronic idiopathic urticaria
Source: FDA Label

CETIRIZINE HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 9 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to CETIRIZINE HYDROCHLORIDE

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

DESLORATADINE AND PSEUDOEPHEDRINE SULFATE 24 HOUR
DESLORATADINE
2 shared
Dr. Reddy's
Shared indications:
Perennial Allergic RhinitisChronic Idiopathic Urticaria
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CETIRIZINE HYDROCHLORIDE FDA Label Details

Indications & Usage

CETIRIZINE HYDROCHLORIDE is indicated for the treatment of Perennial allergic rhinitis; Chronic idiopathic urticaria.

Looking for the branded version?

ZERVIATE

Full clinical data, patents, trials, and competitive landscape for cetirizine hydrochloride.

See ZERVIATE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.